The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: A randomized, double-blind, intrapatient left-to-right study

Journal of the American Academy of Dermatology

Volumn 66, Issue 5, 2012, Pages 807-812

  Treewittayapoom, Chanitwan ^a   Singvahanont, Piyavadee ^a   Chanprapaph, Kumutnart ^a   Haneke, Eckart ^b,c,d,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Dermaticum   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d GHENT UNIVERSITY   (Belgium)

^e Centro Dermatol   (Portugal)

Author keywords

595 nm pulsed dye laser; nail psoriasis; Nail Psoriasis Severity Index; pulse duration

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOLOGIST; DOUBLE BLIND PROCEDURE; FEMALE; FINGERNAIL PSORIASIS; HUMAN; HYPERPIGMENTATION; MALE; NAIL BED; PATIENT ASSESSMENT; PETECHIA; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PULSED DYE LASER; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; LASER THERAPY, LOW-LEVEL; LASERS, DYE; MALE; MIDDLE AGED; NAIL DISEASES; PSORIASIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; THAILAND; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859820790     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.12.015     Document Type: Article

References (33)

1. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996;193:300-3.
2. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007;57:1-27. (Pubitemid 46899261)
3. Aktan Ş, İlknur T, Akin Ç, Özkan Ş. Interobserver reliability of the Nail Psoriasis Severity Index. Clin Exp Dermatol 2006;32:141-4. (Pubitemid 46233014)
4. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003;49:206-12. (Pubitemid 36951265)
5. de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998;138:90-5. (Pubitemid 28077943)
6. Sanchez RM, Martin EG, Umbert MP, Llambi MF. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. J Eur Acad Dermatol Venereol 2005;19:573-7.
7. Sanchez RM, Marquez BG, Umbert MP. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. J Eur Acad Dermatol Venereol 2008;22:963-9.
8. Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998;139:655-9. (Pubitemid 28474312)
9. Tzung TY, Chen CY, Yang CY, Lo PY, Chen YH. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis. Acta Derm Venereol 2008;88:279-80.
10. Rigopoulos D, Ioannides D, Prastitis N, Katsambas A. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm Venereol 2002;82:140. (Pubitemid 34596692)
11. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009;145:269-71.
12. Scher RK, Stiller M, Zhu YI. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001;68:355-8. (Pubitemid 33756739)
13. Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with tazarotene cream 0.1% vs clobetasol propionate 0.05% cream: a double-blind study. Acta Derm Venereol 2007;87:167-8. (Pubitemid 46513205)
14. Yamamoto T, Katayama I, Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J Dermatol 1998;25:231-3. (Pubitemid 28216916)
15. Schissel DJ, Elston DM. Topical 5-fluorouracil treatment for psoriatic trachyonychia. Cutis 1998;62:27-8. (Pubitemid 128474120)
16. Cannavo SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology 2003;206:153-6. (Pubitemid 36205284)
17. Handfield-Jones SE, Boyle J, Harman RR. Local PUVA treatment for nail psoriasis. Br J Dermatol 1987;116:280-1.
18. Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 2008;159:453-6. (Pubitemid 352009870)
19. Saraceno R, Bianchi L, Pietroleonardo L, Giunta A, Mazzotta A, Chimenti S. Remission and time of resolution of nail psoriasis: a comparison among antitumor necrosis factor-alpha inhibitors. Br J Dermatol 2008;159:1418, P47.
20. Rallis E, Stavropoulou E, Rigopoulos D, Verros C. Rapid response of nail psoriasis to etanercept. J Rheumatol 2008;35:544-5. (Pubitemid 351374441)
21. Körver JE, Langewouters AM, Van De Kerkhof PC, Pasch MC. Therapeutic effects of a 12-week course of alefacept on nail psoriasis. J Eur Acad Dermatol Venereol 2006;20:1252-5. (Pubitemid 44614624)
22. Rigopoulos D, Gregoriou S, Lazaridou E, Belyayeva E, Apalla Z, Makris M, et al. Treatment of nail psoriasis with adalimumab: an open label unblinded study. J Eur Acad Dermatol Venereol 2010;24:530-4.
23. De Leeuw J, Van Lingen RG, Both H, Tank B, Nijsten T, Neumann HAM. A comparative study on the efficacy of treatment with 585 nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg 2009;35:80-91.
24. Ilknur T, Akarsu S, Aktan S, Ozkan S. Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasol propionate + salicylic acid on psoriatic plaques. Dermatol Surg 2006;32:49-55.
25. De Leeuw J, Tank B, Bjerring PJ, Koetsveld S, Neumann M. Concomitant treatment of psoriasis of the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a prospective open study in 41 patients. J Am Acad Dermatol 2006;54:266-71. (Pubitemid 43144396)
26. Taibjee SM, Cheung ST, Laube S, Lanigan SW. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis. Br J Dermatol 2005;153:960-6. (Pubitemid 41540761)
27. Erceg A, Bovenschen HJ, van de Kerkhof PC, Seyger MM. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study. Br J Dermatol 2006;155:110-4. (Pubitemid 43876402)
28. Fernandez-Guarino M, Harto A, Sanchez-Ronco M, Garcia-Morales I, Jaen P. Pulsed dye laser vs photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study. J Eur Acad Dermatol Venereol 2009;23:891-5.
29. Oram Y, Karincaoǧlu Y, Koyuncu E, Kaharaman F. Pulsed dye laser in the treatment of nail psoriasis. Dermatol Surg 2010;36:377-81.
30. Hern S, Stanton AW, Mellor RH, Harland CC, Levick JR, Mortimer PS. In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment. Br J Dermatol 2005;152:505-11. (Pubitemid 40547124)
31. Bovenschen HJ, Erceg A, Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. J Dermatolog Treat 2007;18:32-9. (Pubitemid 46410641)
32. Noborio R, Kurokawa M, Kobayashi K, Morita A. Evaluation of the clinical and immunohistological efficacy of the 585-nm pulsed dye laser in the treatment of psoriasis. J Eur Acad Dermatol Venereol 2009;23:420-4.
33. Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol 1977;68:53-60. (Pubitemid 8019017)